Heights Capital Management »

Crescent Biopharma shares owned by Heights Capital Management

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Heights Capital Management from 13F filings

Historical chart of Heights Capital Management investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Heights Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Heights Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.1M 264k 11.86

More positions owned by Heights Capital Management

Flutter Entmt SHS (FLUT)
Nano Nuclear Energy Put Option (NNE)
Fg Merger Ii Corp (FGMC)
Jackson Acquisition Co Ii Com Shs Cl A (JACS)
Drugs Made In Amer Acqutn Ord Shs (DMAA)
Drugs Made In Amer Acq Ii Unit 09/16/2030 (DMIIU)
Churchill Cap Corp Xi Unit 12/10/2030 (CCXIU)
Kochav Defense Acqui Shs Cl A (KCHV)
Iron Horse Acquisit Corp Ii Unit 07/11/2030 (IRHOU)
Empery Digital Com New (EMPD)
Nmp Acquisition Corp Cl A (NMP)
Gp-act Iii Acquisition Corp Cl A (GPAT)
Absci Corp (ABSI)
Fifth Era Acquisition Corp I Ord Shs Cl A (FERA)
Nyxoah S A SHS (NYXH)

View all positions for Heights Capital Management

Top funds holding Crescent Biopharma

Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Vestal Point Capital
FMR
BVF
Opaleye Management
Tang Capital Management
ADAR1 Capital Management
Logos Global Management
Vanguard Group
Perceptive Advisors
Deep Track Capital
Boxer Capital Management
Rtw Investments

View all funds holding Crescent Biopharma